TEVA-FROVATRIPTAN 2.5 MG
FROVATRIPTAN (FROVATRIPTAN SUCCINATE) : 2.5 MG · DIN 02415844 · ENDO OPERATIONS LTD.
Health Canada status: CANCELLED POST MARKET
What is TEVA-FROVATRIPTAN?
TEVA-FROVATRIPTAN 2.5 MG contains FROVATRIPTAN (FROVATRIPTAN SUCCINATE) : 2.5 MG. It is listed in the Health Canada Drug Product Database under DIN 02415844, held by ENDO OPERATIONS LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Jul-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TEVA-FROVATRIPTAN used for?
TEVA-FROVATRIPTAN (frovatriptan tablets) is indicated for the acute treatment of migraine attacks with or without aura in adults. It is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic, ophthalmoplegic or basilar migraine.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02415844 |
|---|---|
| Brand name | TEVA-FROVATRIPTAN |
| Generic / active ingredient | FROVATRIPTAN (FROVATRIPTAN SUCCINATE) : 2.5 MG |
| Manufacturer | ENDO OPERATIONS LTD. |
| Strength | 2.5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N02CC07 FROVATRIPTAN |
| AHFS class | 28:32.28 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Jul-2026 |
| Original market date | 2015-01-16 00:00:00 |
How is it stored and handled?
null
How is it supplied?
blister cards of 7 tablets, 1 blister card per carton
What can be used instead?
Other Canadian products sharing ATC code N02CC07 FROVATRIPTAN. 5 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-FROVATRIPTAN | 2.5 MG | TABLET | APOTEX INC | MARKETED | DIN 02426471 |
| FROVA | 2.5 MG | TABLET | ENDO OPERATIONS LTD. | MARKETED | DIN 02257084 |
| FROVATRIPTAN | 2.5 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02535475 |
| JAMP FROVATRIPTAN | 2.5 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02497131 |
| MINT-FROVATRIPTAN | 2.5 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02509687 |
Who else supplies FROVATRIPTAN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FROVATRIPTAN appears in 17 registered pack listings across 6 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.